Setbacks put drug firms under pressure
The pharmaceuticals sector was under pressure today after high-profile setbacks for AstraZeneca and GlaxoSmithKline spooked investors.
Shares in AstraZeneca plunged more than 8% after it ditched experimental stroke drug NXY-059 following its failure during clinical trials.





